Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules—such as nucleic acids, proteins, and lipids—are major targets of damage by free radicals generated through iron-mediated processes. Iron, due to its ability to cycle between Fe(II) and Fe(III) oxidation states, can catalyze the formation of highly reactive oxygen species (ROS), including hydroxyl radicals (·OH), which initiate oxidative damage in cells. This process leads to lipid peroxidation, protein oxidation, and DNA damage, resulting in various biological consequences like apoptosis, necrosis, and ferroptosis. While low levels of free radical generation play roles in signaling and defense against pathogens, overproduction leads to oxidative stress implicated in chronic diseases such as cancer, neurodegeneration, cardiovascular disease, and tissue injury following ischemia-reperfusion events.
Redox cycling between Fe(II)/Fe(III); Fenton chemistry; initiation/propagation of free radicals
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules via iron-mediated free radical generation.